Literature DB >> 12392128

Recovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review.

Bridget Candy1, Trudie Chalder, Anthony J Cleare, Simon Wessely, Peter D White, Matthew Hotopf.   

Abstract

Infectious mononucleosis is usually an acute, transiently incapacitating condition, but for some sufferers it precipitates chronic illness. It is unclear which patients are at risk of a prolonged state of illness following onset of infectious mononucleosis and if there are any useful preventive measures that would facilitate recovery. The aim of this study was to review all cohort studies and intervention trials that provide information on: (a) the longitudinal course of ill health subsequent to the onset of infectious mononucleosis; (b) the relationship between psychosocial and clinical factors and recovery rate; and (c) the effect of interventions on recovery. A systematic review was conducted, based on a search of the PSYCHINFO, MEDLINE, EMBASE and CINHAL databases up to October 2001, and ISI Science and Social Sciences Citation Indices up to 22 November 2001. Eight papers were identified that gave data on illness following onset of infectious mononucleosis. The best evidence concluded that there is a distinct fatigue syndrome after infectious mononucleosis. Eight papers explored risk factors for prolonged illness following acute infectious mononucleosis. Results varied on the association of acute illness characteristics and psychological features with prolonged ill health. Poor physical functioning, namely lengthy convalescence and being less fit or active, consistently predicted chronic ill health. Three trials reported on interventions that aimed to shorten the time taken to resolve symptoms after uncomplicated infectious mononucleosis. None of the drug trials found any evidence that drug therapy shortens recovery time. The trial that compared the effect of activity with imposed bed rest, found that those patients allowed out of bed as soon as they felt able reported a quicker recovery. More information is needed on the course of ill health subsequent to the onset of infectious mononucleosis. Certain risk factors associated with delay may be amenable to a simple intervention in primary care.

Entities:  

Mesh:

Year:  2002        PMID: 12392128      PMCID: PMC1316091     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  42 in total

1.  Clinical and psychosocial predictors of illness duration from randomised controlled trial of prescribing strategies for sore throat.

Authors:  P Little; C Gould; I Williamson; G Warner; M Gantley; A L Kinmonth
Journal:  BMJ       Date:  1999-09-18

2.  Acute infectious mononucleosis: characteristics of patients who report failure to recover.

Authors:  D S Buchwald; T D Rea; W J Katon; J E Russo; R L Ashley
Journal:  Am J Med       Date:  2000-11       Impact factor: 4.965

3.  INFECTIOUS MONONUCLEOSIS. 2. RELATION OF BED REST AND ACTIVITY TO PROGNOSIS.

Authors:  W DALRYMPLE
Journal:  Postgrad Med       Date:  1964-04       Impact factor: 3.840

4.  Ego strength and length of recovery from infectious mononucleosis.

Authors:  N S GREENFIELD; R ROESSLER; A P CROSLEY
Journal:  J Nerv Ment Dis       Date:  1959-02       Impact factor: 2.254

5.  Acyclovir for treatment of infectious mononucleosis: a meta-analysis.

Authors:  D Torre; R Tambini
Journal:  Scand J Infect Dis       Date:  1999

6.  Patients' expressions of complaints as a predictor of the course of acute hepatitis A.

Authors:  M Rose; G Scholler; A Jörres; G Danzer; B F Klapp
Journal:  J Psychosom Res       Date:  2000-02       Impact factor: 3.006

7.  Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus.

Authors:  T D Rea; J E Russo; W Katon; R L Ashley; D S Buchwald
Journal:  J Am Board Fam Pract       Date:  2001 Jul-Aug

Review 8.  Infectious mononucleosis. Complexities of a common syndrome.

Authors:  S E Godshall; J T Kirchner
Journal:  Postgrad Med       Date:  2000-06       Impact factor: 3.840

9.  Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome.

Authors:  P Powell; R P Bentall; F J Nye; R H Edwards
Journal:  BMJ       Date:  2001-02-17

10.  Infectious mononucleosis: psychological symptoms during acute and subacute phases of illness.

Authors:  W Katon; J Russo; R L Ashley; D Buchwald
Journal:  Gen Hosp Psychiatry       Date:  1999 Jan-Feb       Impact factor: 3.238

View more
  11 in total

Review 1.  Chronic fatigue syndrome.

Authors:  Steven Reid; Trudie Chalder; Anthony Cleare; Matthew Hotopf; Simon Wessely
Journal:  BMJ Clin Evid       Date:  2011-05-26

2.  Incidence of Infectious Mononucleosis in Universities and U.S. Military Settings.

Authors:  Yolonda J Williams-Harmon; Leonard A Jason; Ben Z Katz
Journal:  J Diagn Tech Biomed Anal       Date:  2014-11-21

Review 3.  Chronic fatigue syndrome.

Authors:  Steven F Reid; Trudie Chalder; Anthony Cleare; Matthew Hotopf; Simon Wessely
Journal:  BMJ Clin Evid       Date:  2008-08-28

Review 4.  Host genetics of Epstein-Barr virus infection, latency and disease.

Authors:  Charlotte J Houldcroft; Paul Kellam
Journal:  Rev Med Virol       Date:  2014-11-27       Impact factor: 6.989

5.  The incidence of epstein-barr virus primary infection among suspected patients referred to namazi hospital of shiraz, iran.

Authors:  Mahsa Moeini; Mazyar Ziyaeyan; Sadaf Asaei; Mohammad Amin Behzadi
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

6.  Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome.

Authors:  Alice Russell; Nilay Hepgul; Naghmeh Nikkheslat; Alessandra Borsini; Zuzanna Zajkowska; Natalie Moll; Daniel Forton; Kosh Agarwal; Trudie Chalder; Valeria Mondelli; Matthew Hotopf; Anthony Cleare; Gabrielle Murphy; Graham Foster; Terry Wong; Gregor A Schütze; Markus J Schwarz; Neil Harrison; Patricia A Zunszain; Carmine M Pariante
Journal:  Psychoneuroendocrinology       Date:  2018-12-17       Impact factor: 4.905

Review 7.  Epstein-Barr virus and its association with disease - a review of relevance to general practice.

Authors:  Anders Fugl; Christen Lykkegaard Andersen
Journal:  BMC Fam Pract       Date:  2019-05-14       Impact factor: 2.497

Review 8.  Steroids for symptom control in infectious mononucleosis.

Authors:  Emtithal Rezk; Yazan H Nofal; Ammar Hamzeh; Muhammed F Aboujaib; Mohammad A AlKheder; Muhammad F Al Hammad
Journal:  Cochrane Database Syst Rev       Date:  2015-11-08

9.  Vitamin D levels and monospot tests in military personnel with acute pharyngitis: a retrospective chart review.

Authors:  Sean R Maloney; David Almarines; Paula Goolkasian
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

Review 10.  A clinical primer for the expected and potential post-COVID-19 syndromes.

Authors:  Brian Walitt; Elizabeth Bartrum
Journal:  Pain Rep       Date:  2021-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.